Total Payments
$37,769
2024 Payments
$13.15
Companies
10
Transactions
41
Medicare Patients
442
Medicare Billing
$84,954
Payment Breakdown by Category
Consulting$37,306 (98.8%)
Food & Beverage$292.24 (0.8%)
Travel$171.20 (0.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $37,306 | 20 | 98.8% |
| Food and Beverage | $292.24 | 20 | 0.8% |
| Travel and Lodging | $171.20 | 1 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Shire North American Group Inc | $37,477 | 21 | $0 (2018) |
| IDORSIA PHARMACEUTICALS US INC | $159.13 | 11 | $0 (2024) |
| Collegium Pharmaceutical, Inc. | $27.40 | 2 | $0 (2020) |
| Phadia US Inc. | $18.86 | 1 | $0 (2023) |
| Siemens Medical Solutions USA, Inc. | $15.97 | 1 | $0 (2019) |
| GENZYME CORPORATION | $15.09 | 1 | $0 (2021) |
| Ferring Pharmaceuticals Inc. | $14.78 | 1 | $0 (2022) |
| Biohaven Pharmaceutical Holding Company Ltd. | $14.25 | 1 | $0 (2022) |
| Lucid Diagnostics Inc. | $13.80 | 1 | $0 (2022) |
| RedHill Biopharma Inc. | $12.96 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $13.15 | 1 | IDORSIA PHARMACEUTICALS US INC ($13.15) |
| 2023 | $164.84 | 11 | IDORSIA PHARMACEUTICALS US INC ($145.98) |
| 2022 | $42.83 | 3 | Ferring Pharmaceuticals Inc. ($14.78) |
| 2021 | $28.05 | 2 | GENZYME CORPORATION ($15.09) |
| 2020 | $27.40 | 2 | Collegium Pharmaceutical, Inc. ($27.40) |
| 2019 | $15.97 | 1 | Siemens Medical Solutions USA, Inc. ($15.97) |
| 2018 | $4,007 | 2 | Shire North American Group Inc ($4,007) |
| 2017 | $33,470 | 19 | Shire North American Group Inc ($33,470) |
All Payment Transactions
41 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/14/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: Insomnia | ||||||
| 12/22/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $11.19 | General |
| Category: INSOMNIA | ||||||
| 12/06/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $9.28 | General |
| Category: INSOMNIA | ||||||
| 11/13/2023 | Phadia US Inc. | ImmunoCAP (Device) | Food and Beverage | Cash or cash equivalent | $18.86 | General |
| Category: Allergy/Immunology | ||||||
| 10/10/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $9.60 | General |
| Category: INSOMNIA | ||||||
| 09/16/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $19.41 | General |
| Category: INSOMNIA | ||||||
| 08/02/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: INSOMNIA | ||||||
| 05/12/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: INSOMNIA | ||||||
| 05/02/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $8.85 | General |
| Category: INSOMNIA | ||||||
| 04/26/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $21.77 | General |
| Category: INSOMNIA | ||||||
| 03/22/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: INSOMNIA | ||||||
| 02/24/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $12.70 | General |
| Category: INSOMNIA | ||||||
| 10/11/2022 | Ferring Pharmaceuticals Inc. | EUFLEXXA (Device) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: ORTHOPEDICS | ||||||
| 09/22/2022 | Lucid Diagnostics Inc. | — | Food and Beverage | In-kind items and services | $13.80 | General |
| 08/30/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: PRIMARY CARE | ||||||
| 09/21/2021 | GENZYME CORPORATION | FABRAZYME (Biological) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: Genetic Disease | ||||||
| 05/18/2021 | RedHill Biopharma Inc. | Movantik (Drug), Talicia | Food and Beverage | In-kind items and services | $12.96 | General |
| Category: Opioid Antagonist | ||||||
| 11/18/2020 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $14.96 | General |
| Category: Opioid Analgesic | ||||||
| 09/23/2020 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $12.44 | General |
| Category: Opioid Analgesic | ||||||
| 04/25/2019 | Siemens Medical Solutions USA, Inc. | Atellica (Device) | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: DX - Diagnostics incl. all products and services | ||||||
| 05/07/2018 | Shire North American Group Inc | — | Consulting Fee | Cash or cash equivalent | $2,007.00 | General |
| 05/07/2018 | Shire North American Group Inc | — | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| 12/20/2017 | Shire North American Group Inc | — | Consulting Fee | Cash or cash equivalent | $2,007.00 | General |
| 12/01/2017 | Shire North American Group Inc | — | Consulting Fee | Cash or cash equivalent | $1,900.00 | General |
| 11/20/2017 | Shire North American Group Inc | — | Consulting Fee | Cash or cash equivalent | $2,007.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 168 | 639 | $88,568 | $31,066 |
| 2022 | 9 | 145 | 602 | $75,992 | $26,299 |
| 2021 | 7 | 117 | 542 | $73,747 | $25,800 |
| 2020 | 1 | 12 | 22 | $4,620 | $1,789 |
Total Patients
442
Total Services
1,805
Medicare Billing
$84,954
Procedure Codes
26
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 41 | 163 | $34,230 | $14,378 | 42.0% |
| 96521 | Refilling and maintenance of portable pump | Office | 2023 | 12 | 74 | $24,050 | $6,805 | 28.3% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 14 | 74 | $10,284 | $3,502 | 34.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 23 | 38 | $5,396 | $2,204 | 40.8% |
| 95924 | Testing of autonomic (sympathetic and parasympathetic) nervous system function, at least 5 minutes of tilt | Office | 2023 | 13 | 16 | $4,832 | $1,834 | 38.0% |
| 96366 | Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | Office | 2023 | 13 | 73 | $6,262 | $1,121 | 17.9% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 16 | 34 | $1,284 | $553.92 | 43.1% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 12 | 140 | $1,960 | $450.09 | 23.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 24 | 27 | $270.00 | $218.40 | 80.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 28 | 134 | $28,337 | $12,493 | 44.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 26 | 52 | $7,205 | $3,314 | 46.0% |
| 99491 | Chronic care management services for two or more chronic conditions, first 30 minutes provided personally by health care professional, per calendar month | Office | 2022 | 17 | 44 | $6,461 | $2,648 | 41.0% |
| 97530 | Therapy procedure using functional activities | Office | 2022 | 13 | 101 | $12,934 | $2,545 | 19.7% |
| 97112 | Therapy procedure to re-educate brain-to-nerve-to-muscle function, each 15 minutes | Office | 2022 | 12 | 83 | $7,470 | $1,654 | 22.1% |
| 95924 | Testing of autonomic (sympathetic and parasympathetic) nervous system function, at least 5 minutes of tilt | Office | 2022 | 12 | 14 | $4,228 | $1,615 | 38.2% |
| 97110 | Therapy procedure using exercise to develop strength, endurance, range of motion, and flexibility, each 15 minutes | Office | 2022 | 13 | 80 | $5,177 | $1,283 | 24.8% |
| 97032 | Application of electrical stimulation with therapist present, each 15 minutes | Office | 2022 | 11 | 81 | $4,050 | $707.10 | 17.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 13 | 13 | $130.00 | $38.40 | 29.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 33 | 137 | $28,770 | $13,285 | 46.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 24 | 75 | $10,657 | $5,063 | 47.5% |
| 97530 | Therapeutic activities to improve function, with one-on-one contact between patient and provider, each 15 minutes | Office | 2021 | 13 | 171 | $22,230 | $4,188 | 18.8% |
| 99491 | Chronic care management services by qualified health care professional, 30 minutes or more per calendar month | Office | 2021 | 13 | 25 | $3,725 | $1,454 | 39.0% |
| 97112 | Therapeutic procedure to re-educate brain-to-nerve-to-muscle function, each 15 minutes | Office | 2021 | 12 | 55 | $4,950 | $1,160 | 23.4% |
| 97032 | Application of electrical stimulation to 1 or more areas, each 15 minutes | Office | 2021 | 11 | 65 | $3,275 | $606.72 | 18.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 11 | 14 | $140.00 | $42.00 | 30.0% |
About Dr. Nathan Eliason, MD
Dr. Nathan Eliason, MD is a Specialist healthcare provider based in Murray, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1073557583.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nathan Eliason, MD has received a total of $37,769 in payments from pharmaceutical and medical device companies, with $13.15 received in 2024. These payments were reported across 41 transactions from 10 companies. The most common payment nature is "Consulting Fee" ($37,306).
As a Medicare-enrolled provider, Eliason has provided services to 442 Medicare beneficiaries, totaling 1,805 services with total Medicare billing of $84,954. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Other Specialties Adult Medicine
- Location Murray, UT
- Active Since 06/15/2006
- Last Updated 11/27/2023
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1073557583
Products in Payments
- QUVIVIQ (Drug) $159.13
- XTAMPZA (Drug) $27.40
- ImmunoCAP (Device) $18.86
- Atellica (Device) $15.97
- FABRAZYME (Biological) $15.09
- EUFLEXXA (Device) $14.78
- NURTEC ODT (Drug) $14.25
- Movantik (Drug) $12.96
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Murray
Sunny Pandita, Md, MD
Specialist — Payments: $25,205
Specialist $25,205
Rafael Firszt, M.d, M.D
Specialist — Payments: $24,591
Specialist $24,591
Gary Symkoviak, M.d, M.D
Specialist — Payments: $6,021
Specialist $6,021
Dr. Jacques Youssef, M.d, M.D
Specialist — Payments: $2,641
Specialist $2,641
Charles Dunkley, Do, DO
Specialist — Payments: $2,401
Specialist $2,401
Dr. Russell Haupt, Md, MD
Specialist — Payments: $1,358
Specialist $1,358